ID23735A - Tablet trovafloksasin mesilat - Google Patents

Tablet trovafloksasin mesilat

Info

Publication number
ID23735A
ID23735A IDP990036D ID990036D ID23735A ID 23735 A ID23735 A ID 23735A ID P990036 D IDP990036 D ID P990036D ID 990036 D ID990036 D ID 990036D ID 23735 A ID23735 A ID 23735A
Authority
ID
Indonesia
Prior art keywords
trovafloksasin
mesilat
tablet
trovafloksasin mesilat
tablet trovafloksasin
Prior art date
Application number
IDP990036D
Other languages
English (en)
Indonesian (id)
Inventor
Alton Dale Johnson
Christopher Michael Sinko
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ID23735A publication Critical patent/ID23735A/id

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IDP990036D 1998-01-21 1999-01-15 Tablet trovafloksasin mesilat ID23735A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7201398P 1998-01-21 1998-01-21

Publications (1)

Publication Number Publication Date
ID23735A true ID23735A (id) 2000-05-11

Family

ID=22105016

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP990036D ID23735A (id) 1998-01-21 1999-01-15 Tablet trovafloksasin mesilat

Country Status (34)

Country Link
US (1) US6187341B1 (fr)
EP (1) EP0930068A3 (fr)
JP (1) JPH11269072A (fr)
KR (1) KR100314977B1 (fr)
CN (1) CN1227743A (fr)
AP (1) AP1094A (fr)
AR (1) AR012780A1 (fr)
AU (1) AU758381B2 (fr)
BG (1) BG103106A (fr)
BR (1) BR9900116A (fr)
CA (1) CA2259698C (fr)
CO (1) CO4810225A1 (fr)
DZ (1) DZ2712A1 (fr)
EA (1) EA003247B1 (fr)
GT (1) GT199900004A (fr)
HR (1) HRP990023A2 (fr)
HU (1) HUP9900154A3 (fr)
ID (1) ID23735A (fr)
IL (1) IL128051A0 (fr)
IS (1) IS4947A (fr)
MA (1) MA24747A1 (fr)
NO (1) NO990243L (fr)
NZ (1) NZ333838A (fr)
OA (1) OA10958A (fr)
PA (1) PA8466701A1 (fr)
PE (1) PE20000169A1 (fr)
PL (1) PL330981A1 (fr)
SG (1) SG70666A1 (fr)
SK (1) SK4299A3 (fr)
TN (1) TNSN99007A1 (fr)
TR (1) TR199900089A3 (fr)
TW (1) TW518224B (fr)
YU (1) YU2399A (fr)
ZA (1) ZA99393B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ292069B6 (cs) * 1998-11-10 2003-07-16 Bayer Aktiengesellschaft Farmaceutický přípravek zahrnující moxifloxacin, způsob výroby a použití tohoto přípravku
KR20020032611A (ko) * 1999-09-20 2002-05-03 스톤 스티븐 에프. 약물의 다형성 전환을 경감시키기 위한 공정
AR025976A1 (es) * 1999-10-08 2002-12-26 Affinium Pharm Inc Inhibidores de fab i.
FR2808441B1 (fr) * 2000-05-04 2004-06-18 Oreal Utilisation de fibres dans une composition de soin ou de maquillage pour matifier la peau
DE10031043A1 (de) * 2000-06-26 2002-02-14 Bayer Ag Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung
DE60230934D1 (de) * 2001-04-06 2009-03-05 Affinium Pharm Inc Fab-i-inhibitoren
EP1396263A1 (fr) 2002-08-09 2004-03-10 Warner-Lambert Company Compositions d'enrobage pour tablettes et caplets
DK1575951T3 (da) 2002-12-06 2014-09-15 Debiopharm Int Sa Heterocykliske forbindelser, fremgangsmåder til fremstilling deraf og deres anvendelse i terapi
CN100415284C (zh) * 2002-12-30 2008-09-03 毛友昌 六味木香片的制备方法
JP4880448B2 (ja) 2003-03-17 2012-02-22 アフィナム ファーマシューティカルズ,インコーポレーテッド 複数の抗生物質を含む組成物、及びそれを用いる方法
ES2297067T3 (es) * 2003-03-19 2008-05-01 The Jordanian Pharmaceutical Manufacturing Co. Ltd. Composiciones farmaceuticas no higroscopicas que contienen acidos quinolinacarboxilicos de hidratados.
US8906413B2 (en) * 2003-05-12 2014-12-09 Supernus Pharmaceuticals, Inc. Drug formulations having reduced abuse potential
CA2531637A1 (fr) * 2003-07-23 2005-02-03 L. Perrigo Company Composition contenant des fibres cellulosiques
CA2568914C (fr) 2004-06-04 2013-09-24 Affinium Pharmaceuticals, Inc. Agents therapeutiques, et methodes de fabrication et d'utilisation
EP1809259B1 (fr) * 2004-10-15 2014-12-03 Supernus Pharmaceuticals, Inc. Preparations pharmaceutiques pour lesquelles le risque d'abus est reduit
KR20080075027A (ko) * 2005-12-05 2008-08-13 아피늄 파마슈티컬스, 인크. Fabi 억제제 및 항박테리아제로서의헤테로시클릴아크릴아미드 화합물
JP5468899B2 (ja) 2006-07-20 2014-04-09 アフィニウム ファーマシューティカルズ, インク. Fabiインヒビターとしてのアクリルアミド誘導体
US8263613B2 (en) * 2007-02-16 2012-09-11 Affinium Pharmaceuticals, Inc. Salts, prodrugs and polymorphs of fab I inhibitors
EP2861608B8 (fr) 2012-06-19 2019-06-19 Debiopharm International SA Dérivés de type promédicament du (e)-n-méthyl-n-((3-méthylbenzofuran-2-yl) méthyl)-3-(7-oxo-5,6,7,8-tétrahydro-l,8-naphtyridin-3-yl)acrylamide
JP6998881B2 (ja) 2016-02-26 2022-02-10 デビオファーム・インターナショナル・エス・アー 糖尿病性足感染症の処置のための医薬

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5286754A (en) 1986-01-21 1994-02-15 Bayer Aktiengesellschaft Pharmaceutical formulations of ciprofloxacin
DE3601566A1 (de) * 1986-01-21 1987-07-23 Bayer Ag Pharmazeutische zubereitungen von ciprofloxacin
US4957554A (en) 1989-08-16 1990-09-18 Minnesota Mining And Manufacturing Company Dimensionally-controlled ceramics
DE4120646A1 (de) 1991-06-22 1992-12-24 Bayer Ag 7-isoindolinyl-chinolon- und naphthyridoncarbonsaeure-derivate
PL325170A1 (en) * 1995-08-29 1998-07-06 Pfizer Bipolar forms of throwaflocacin

Also Published As

Publication number Publication date
KR19990068014A (ko) 1999-08-25
EP0930068A2 (fr) 1999-07-21
CA2259698C (fr) 2003-04-15
YU2399A (sh) 2002-06-19
NO990243L (no) 1999-07-22
CO4810225A1 (es) 1999-06-30
BR9900116A (pt) 2000-05-02
TR199900089A2 (xx) 1999-10-21
CN1227743A (zh) 1999-09-08
CA2259698A1 (fr) 1999-07-21
IL128051A0 (en) 1999-11-30
IS4947A (is) 1999-07-22
HRP990023A2 (en) 1999-08-31
PL330981A1 (en) 1999-08-02
EP0930068A3 (fr) 1999-12-22
TW518224B (en) 2003-01-21
BG103106A (en) 1999-08-31
AR012780A1 (es) 2000-11-08
DZ2712A1 (fr) 2003-09-01
TNSN99007A1 (fr) 2005-11-10
EA199900046A3 (ru) 1999-12-29
HUP9900154A3 (en) 2000-12-28
OA10958A (en) 2001-10-31
PE20000169A1 (es) 2000-03-10
EA199900046A2 (ru) 1999-08-26
MA24747A1 (fr) 1999-10-01
SG70666A1 (en) 2000-02-22
NO990243D0 (no) 1999-01-20
TR199900089A3 (tr) 1999-10-21
GT199900004A (es) 2000-07-08
PA8466701A1 (es) 2000-09-29
HUP9900154A2 (hu) 1999-09-28
AP9901443A0 (en) 1999-03-31
AU1217399A (en) 1999-08-12
AU758381B2 (en) 2003-03-20
NZ333838A (en) 2000-03-27
AP1094A (en) 2002-08-19
HU9900154D0 (en) 1999-03-29
ZA99393B (en) 2000-07-21
SK4299A3 (en) 2000-06-12
KR100314977B1 (ko) 2001-11-24
JPH11269072A (ja) 1999-10-05
EA003247B1 (ru) 2003-02-27
US6187341B1 (en) 2001-02-13

Similar Documents

Publication Publication Date Title
ATE341990T1 (de) Sigmidoskop
IS5869A (is) Hraðlosandi tafla
DE59901560D1 (de) Retrograder tibianagel
DE59902874D1 (de) Buchsenkontakt
ID23735A (id) Tablet trovafloksasin mesilat
DE59903966D1 (de) Exzenterzahnradgetriebe
ATE262513T1 (de) Benzoylpyridazine
DE59903106D1 (de) Tripode-gleichlaufdrehgelenk
ATE237529T1 (de) Tablettenspender
DE59901046D1 (de) Methylcyclotetradec-5-en-1-one
DE59807217D1 (de) Nadellager
DE1118098T1 (de) Mehrfachflussigelektrosprühschnittstelle
DE59808995D1 (de) Endomikroskopsystem
DE19842103B4 (de) Stanznietzuführung
DK1051156T3 (da) Farmaceutiske præparater
DE29801440U1 (de) Tabletten-Einnahmehilfe
DE59902088D1 (de) Achrathermer Reimager
DE59900612D1 (de) Dispersionsazofarbstoffmischungen
DE59903616D1 (de) Rollenwicklerwalze
DE59901263D1 (de) Einzelplatz-sortierer
DE29813269U1 (de) Tablette
DE29823505U1 (de) Punkttablette
DE59903771D1 (de) Hydro-transformator
ATA126298A (de) Verpuffungsklappe
DE29819079U1 (de) Kombuchalyophilisat